UCB

UCB sign

UCB unveils plan to build $2B biologics plant in Georgia

UCB will build a $2B manufacturing facility in Atlanta. It will become its first major manufacturing site in the U.S. and will produce biologics.

Kevin Dunleavy Mar 24, 2026 2:56pm

Illustration of multiple orange alarm clocks floating against a blue background scattered at different angles as if suspende

The top 10 drugs losing US exclusivity in 2026

Mar 16, 2026 3:00am

With win over AbbVie's Skyrizi, UCB's Bimzelx remains undefeated

Mar 11, 2026 11:29am

Asia

Kyowa, Sino Biopharm, Duality—Fierce Pharma Asia

Mar 6, 2026 9:35am

UCB sign

UCB reaps the rewards of fast-growing Bimzelx

Feb 27, 2026 11:51am

European Union flag

CHMP backs 6 new meds, will probe Amgen's Tavneos

Jan 30, 2026 12:00pm